These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 30701850)

  • 1. Application of bacterial therapeutic vaccine Immunovac-VP4 in the treatment of pollinosis.
    Kostinov MP; Poddubikova AM; Magarshak OO; Poddubikov AV
    Ter Arkh; 2018 Apr; 90(3):16-20. PubMed ID: 30701850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunovac-VP4 vaccine used in complex allergen-specific immunotherapy of patients with hay fever].
    Poddubikova AM; Kostinov MP
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (4):44-8. PubMed ID: 20799399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific immunotherapy against allergic rhinitis: the state of the art.
    Fujimura T; Okamoto Y
    Allergol Int; 2010 Mar; 59(1):21-31. PubMed ID: 20093851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
    Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
    J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic bacterial vaccine Immunovac in complex treatment of patients with chronic pyoderma].
    Sorokina EV; Masiukova SA; Kurbatova EA; Egorova NB
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (4):31-7. PubMed ID: 20795383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxP3 Tregs Response to Sublingual Allergen Specific Immunotherapy in Children Depends on the Manifestation of Allergy.
    Stelmaszczyk-Emmel A; Zawadzka-Krajewska A; Głodkowska-Mrówka E; Demkow U
    J Immunol Res; 2015; 2015():731381. PubMed ID: 26457309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological changes after ASIT in AD allergen-specific immunotherapy and their potential correlation with clinical response in patients with atopic dermatitis patients sensitized to house dust mite.
    Zhong H; Deng X; Song Z; Darsow U; Chen W; Chen S; Luo N; Hao F
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1318-24. PubMed ID: 25376542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K; Gotoh M
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy].
    Rogala B; Jarzab J; Rymarczyk B; Tłuczykont B
    Wiad Lek; 2004; 57(3-4):123-30. PubMed ID: 15307518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy.
    Fujimura T; Kawamoto S
    Allergol Int; 2015 Oct; 64(4):312-20. PubMed ID: 26433527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Novel type of vaccine with a combination of Toll like receptor agonists--TLR 1/2, 4, 5/6, 9].
    Egorova NB; Kurbatova EA; Gruber IM; Semenova IB; Mikhaĭlova NA; Zverev VV
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (4):40-6. PubMed ID: 21913390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunological parameters and risk factors for pollen-induced allergic rhinitis and asthma].
    Staikūniene J; Sakalauskas R
    Medicina (Kaunas); 2003; 39(3):244-53. PubMed ID: 12695637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term preseasonal immunotherapy: is early clinical efficacy related to the basophil response?
    Kepil Özdemir S; Sin BA; Güloğlu D; İkincioğulları A; Gençtürk Z; Mısırlıgil Z
    Int Arch Allergy Immunol; 2014; 164(3):237-45. PubMed ID: 25170594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pollinex Quattro: an innovative four injections immunotherapy in allergic rhinitis.
    Rosewich M; Lee D; Zielen S
    Hum Vaccin Immunother; 2013 Jul; 9(7):1523-31. PubMed ID: 23584250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
    Hylander T; Latif L; Petersson-Westin U; Cardell LO
    J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
    Scurlock AM
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific immunotherapy in pollinosis: II. Forecasting changes in certain cytoimmunological indicators after four years of immunotherapy in pollinosis.
    Zieliński AE
    J Investig Allergol Clin Immunol; 1996; 6(6):364-70. PubMed ID: 9015780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of pollinosis in children by specific peroral hyposensitization].
    Reviakina VA; Balabolkin II; Vakhrameeva SI; Botvin'eva VV; Ivanov VG
    Pediatriia; 1988; (6):80-2. PubMed ID: 3186412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.